Precious Metals are Becoming Data Assets: How SMX Turns Bullion Into Self-Reporting Materials
AI Sentiment
Highly Positive
8/10
as of 11-28-2025 12:40pm EST
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | CERRITOS |
| Market Cap: | 444.1M | IPO Year: | N/A |
| Target Price: | $6.00 | AVG Volume (30 days): | 3.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.64 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.14 - $4.88 | Next Earning Date: | 11-13-2025 |
| Revenue: | $461,039,000 | Revenue Growth: | 21.67% |
| Revenue Growth (this year): | 21.71% | Revenue Growth (next year): | 20.58% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
TOI Breaking Stock News: Dive into TOI Ticker-Specific Updates for Smart Investing
AI Sentiment
Highly Positive
8/10
AI Sentiment
Positive
7/10
AI Sentiment
Neutral
4/10
AI Sentiment
Highly Positive
8/10
AI Sentiment
Positive
7/10
AI Sentiment
Neutral
5/10
See how TOI stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "TOI The Oncology Institute Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.